β2-glycoprotein I:: antiphospholipid syndrome and T-cell reactivity
β2-glycoprotein I:: antiphospholipid syndrome and T-cell reactivity
复制标题
DOI:
10.1016/j.thromres.2004.06.029
复制
发表时间:
2004-01-01
影响因子:
7.5
通讯作者:
Kuwana, M
中科院分区:
文献类型:
--
作者:
Kuwana, M
There is increasing evidence showing that recurrent thrombosis and intrauterine fetal loss in anti phospholipid syndrome (APS) are attributable to antiphosphotipid (aPL) antibodies. We have recently identified autoreactive CD4(+) T cells to beta(2)-glycoprotein I (beta(2)GPI) that promote production of pathogenic antiphosphotipid antibodies. beta(2)GPI-specific CD4(+) T cells preferentially recognize the antigenic peptide containing the major phospholipid (PL)-binding site in the context of DR53. T-cell helper activity that stimulates B cells to produce IgG anti-beta(2)GPI antibodies is mediated through IL-6 and CD40-CD154 interaction. beta(2)GPI-specific T cells respond to reduced beta(2)GPI and recombinant beta(2)GPI fragments produced in a bacterial expression system but not to native beta(2)GPI, indicating that the epitopes recognized by beta(2)GPI-specific T cells are 'cryptic' determinants, which are generated at a subthreshold level by the processing of native beta(2)GPI under normal circumstances. Although beta(2)GPI-specific T cells are detected in both APS patients and healthy individuals, these autoreactive T cells are activated in vivo in APS patients but not in healthy individuals. These findings indicate activation of beta(2)GPI-specific T cells and subsequent production of pathogenic anti-beta(2)GPI antibodies can be induced by the exposure of such T cells to cryptic peptides of beta(2)GPI efficiently presented by functional antigen-presenting cells (APC). Delineating the mechanisms that induce the efficient processing and presentation of cryptic determinants of beta(2)GPI as a consequence of antigen processing would clarify the etiology that initiates the autoantibody response in APS. (c) 2004 Elsevier Ltd. All rights reserved.